Lidocaine Potentiates the Chondrotoxicity of Methylprednisolone
- 1 April 2009
- journal article
- Published by Wiley in Arthroscopy
- Vol. 25 (4) , 337-347
Abstract
Purpose: This study examined the viability of bovine articular chondrocytes after exposure to methylprednisolone, methylprednisolone with lidocaine, and methylprednisolone in a simulated inflammatory environment. Methods: Bovine articular chondrocytes were suspended in alginate beads and cultured in Dulbecco's modified Eagle's medium/F‐12 for 1 week before experimentation. Suspended chondrocytes were exposed to 0.9% saline solution (negative control), methylprednisolone (4, 8, and 16 mg/mL), methylprednisolone (8 mg/mL) with 1% lidocaine, or methylprednisolone (8 mg/mL) and saline solution in a simulated inflammatory environment (interleukin [IL] 1β exposure, 10 ng/mL) for 15, 30, and 60 minutes. Flow cytometry was performed 1 day, 4 days, and 7 days after exposure by use of annexin V and propidium iodide to assess chondrocyte viability. Results: Chondrocyte viability decreased from 84% in saline solution to 62%, 38%, and 2.4% 1 day after 60 minutes of exposure to 4, 8, and 16 mg/mL of methylprednisolone, respectively (n = 7, P < .05). Chondrotoxicity increased with increasing time of exposure to methylprednisolone and with increasing time after exposure. In IL‐1β–activated chondrocytes, viability decreased from 76% in saline solution to 2.9% after 60 minutes of methylprednisolone exposure (8 mg/mL) (n = 4, P < .05). The combination of 8 mg/mL of methylprednisolone and 1% lidocaine further reduced viability to 1.0% after 60 minutes (n = 4, P < .05). Conclusions: These results show a dose‐ and time‐dependent decrease in chondrocyte viability after exposure to clinically relevant doses of methylprednisolone. The combination of methylprednisolone and lidocaine was toxic, with virtually no cells surviving after treatment. In addition, methylprednisolone did not mitigate the inflammatory effects of IL‐1β; rather, it further potentiated the chondrotoxicity. Clinical Relevance: Intra‐articular injections of corticosteroids and local anesthetics are widely used in clinical practice. This in vitro study provides information on the potential effects of these drugs on articular cartilage.Keywords
This publication has 20 references indexed in Scilit:
- The in vitro effects of bupivacaine on articular chondrocytesThe Journal of Bone and Joint Surgery. British volume, 2008
- Natural chondroitin sulphates increase aggregation of proteoglycan complexes and decrease adamts-5 expression in interleukin 1β-treated chondrocytesAnnals of the Rheumatic Diseases, 2008
- Chondroitin sulfate modulation of matrix and inflammatory gene expression in IL-1β-stimulated chondrocytes – study in hypoxic alginate bead culturesOsteoarthritis and Cartilage, 2008
- Optimizing CO2 normalizes pH and enhances chondrocyte viability during cold storageJournal of Orthopaedic Research, 2007
- Intraarticular corticosteroids decrease synovial RANKL expression in inflammatory arthritisArthritis & Rheumatism, 2006
- Repeated intraarticular injections of triamcinolone acetonide alter cartilage matrix metabolism measured by biomarkers in synovial fluidJournal of Orthopaedic Research, 2005
- A novel two‐step method for the formation of tissue‐engineered cartilage by mature bovine chondrocytes: The alginate‐recovered‐chondrocyte (ARC) methodJournal of Orthopaedic Research, 2003
- Use of synovial fluid markers of cartilage synthesis and turnover to study effects of repeated intra‐articular administration of methylprednisolone acetate on articular cartilage in vivoJournal of Orthopaedic Research, 2001
- Chondroprotective effect of intraarticular injections of interleukin‐1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase‐1 expressionArthritis & Rheumatism, 1996
- Intraarticular Injections with Methylprednisolone Acetate Reduce Osteoarthritic Lesions in Parallel with Chondrocyte Stromelysin Synthesis in Experimental OsteoarthritisArthritis & Rheumatism, 1994